Published in Eur J Cancer on May 01, 1978
Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev (1995) 3.58
Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A (1972) 3.02
Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science (1972) 2.73
[Virus proteins. IV. Constitution of the coat protein of the fd phage]. Hoppe Seylers Z Physiol Chem (1969) 2.56
Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene codes for both the cytosolic and mitochondrial forms. J Biol Chem (1988) 2.43
Opiate agonists and antagonists discriminated by receptor binding in brain. Science (1973) 2.27
Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol (2001) 2.25
Regulation of immune response by autogenous antibody against receptor. Proc Natl Acad Sci U S A (1974) 2.05
Optimization and in situ detection of Escherichia coli beta-galactosidase gene expression in Dictyostelium discoideum. Gene (1989) 2.02
Incidence and frequency or complications and management of Meckel's diverticulum. Surg Gynecol Obstet (1989) 1.98
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci U S A (1991) 1.97
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol (1998) 1.85
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev (2006) 1.80
Differentiation and medical importance of saccharolytic intestinal Bacteroides. Arzneimittelforschung (1974) 1.76
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev (2002) 1.68
Specific suppression of immune responses. Science (1973) 1.67
Macroglobulin structure: homology of mu and gamma heavy chains of human immunoglobulins. Science (1969) 1.64
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int (2007) 1.58
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation (2001) 1.54
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
The response to phosphorylcholine: dissecting an immune response. Transplant Rev (1975) 1.49
Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience (1992) 1.48
Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J Immunol (1992) 1.47
Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl (2001) 1.44
Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med (1976) 1.43
A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
Rapid identification of Escherichia coli by Fluorocult media and positive indole reaction. J Clin Microbiol (1988) 1.41
Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant (1999) 1.40
[Quality assurance in bariatric surgery in Germany--results of the German multicentre trial 2005 and 2006]. Zentralbl Chir (2008) 1.38
[A new butyric acid-producing bacteroides species: B. splanchnicus n. sp. (author's transl)]. Zentralbl Bakteriol Orig A (1975) 1.35
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am J Transplant (2008) 1.34
The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3. J Biol Chem (1981) 1.31
Preparation and analysis of seven major, topographically defined fragments of band 3, the predominant transmembrane polypeptide of human erythrocyte membranes. Biochemistry (1978) 1.30
Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol (1990) 1.29
[Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity (author's transl)]. Dtsch Med Wochenschr (1975) 1.28
Import of cytochrome c into mitochondria. Cytochrome c heme lyase. Eur J Biochem (1987) 1.28
[In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)]. Infection (1977) 1.26
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Klin Wochenschr (1982) 1.26
Clonal restriction of the immune response to phosphorylcholine. Nature (1974) 1.25
Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int (1986) 1.23
Interaction of cimetidine with metoprolol, propranolol, or atenolol. Lancet (1981) 1.22
Physical and conformational properties of staphylokinase in solution. Biochim Biophys Acta (1993) 1.21
Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice. J Immunol (1975) 1.19
Agent Orange and the Vietnamese: the persistence of elevated dioxin levels in human tissues. Am J Public Health (1995) 1.18
RNA polymerase III catalysed transcription can be regulated in Saccharomyces cerevisiae by the bacterial tetracycline repressor-operator system. EMBO J (1992) 1.18
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant (2000) 1.17
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int (2001) 1.17
Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein. Growth Horm IGF Res (2001) 1.16
Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res (1997) 1.16
Sternocostoclavicular hyperostosis: painful swelling of the sternum, clavicles, and upper ribs. Report of two new cases. Ann Intern Med (1977) 1.16
Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15
The cloven hoof in legal medicine. Int J Legal Med (2001) 1.15
Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant (1997) 1.15
The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma. Oncogene (2007) 1.14
Priapism during regular haemodialysis. Lancet (1974) 1.14
[The Bacteroides share of the human intestinal flora]. Zentralbl Bakteriol Orig (1970) 1.14
p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology (1998) 1.14
Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int (1995) 1.12
The nutritive effect of glucose on the structure and function of jejunal self-emptying blind loops in the rat. Gut (1975) 1.12
Establishment of a system for conditional gene expression using an inducible tRNA suppressor gene. Mol Cell Biol (1992) 1.11
A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats. Drugs Exp Clin Res (1987) 1.11
[Isolation of two bacteroides fragilis phages from sewage and detection of lysogenic B. fragilis strains]. Zentralbl Bakteriol Orig A (1972) 1.11
Inhibitory activity of cefotetan and other beta-lactams against anaerobes. J Antimicrob Chemother (1983) 1.10
An opiate-receptor gene family reunion. Trends Neurosci (1994) 1.10
[Chemical analysis of the cell wall of Corynebacterium acnes and C. parvum]. Zentralbl Bakteriol Orig (1968) 1.10
The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein. J Biol Chem (1996) 1.10
Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest (1987) 1.09
Clonal depletion in neonatal tolerance. Science (1974) 1.08
Immune response to phosphorylcholine. III. Requirement of the Fc portion and equal effectiveness of IgG subclasses in anti-receptor antibody-induced suppression. J Immunol (1977) 1.08
Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole. Infection (1989) 1.08
Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis (1995) 1.07
[Serological study of gram-negative sporeless anaerobes, and especially of bacteroides convexus and bacteroides melaninogenicus]. Ann Inst Pasteur (Paris) (1968) 1.07
B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection. Scand J Immunol (1993) 1.06
Idiotypic networks and nature of molecular mimicry: an overview. Methods Enzymol (1989) 1.05
Comparative macrorestriction and RFLP analysis of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis isolates from man, pig, and cattle. Vet Microbiol (2006) 1.05
Positive selection for Dictyostelium discoideum mutants lacking UMP synthase activity based on resistance to 5-fluoroorotic acid. Mol Gen Genet (1991) 1.05
Protein-protein interactions of the primase subunits p58 and p48 with simian virus 40 T antigen are required for efficient primer synthesis in a cell-free system. J Biol Chem (2000) 1.04
[Life threatening infection with bacteroides fragilis in connection with Dalkon shield (author's transl)]. Geburtshilfe Frauenheilkd (1976) 1.04
Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies. J Immunol (1982) 1.04
An immunologic network. Contemp Top Immunobiol (1980) 1.04
Current trends in biocompatibility testing. Proc Inst Mech Eng H (1998) 1.03
[The serological behaviour of strains belonging to the species Bacteroides convexus, B. thetaiotaomicron, B. vulgatus, and B. distasonis]. Zentralbl Bakteriol Orig (1969) 1.03
[Simultaneous occurrence of an open Gartner-duct cyst, a homolateral aplasia of the kidney and a double uterus as a typical syndrome of abnormalities]. Geburtshilfe Frauenheilkd (1971) 1.02
Serological evidence for reactivation of EBV infection due to uraemic immunodeficiency. Nephrol Dial Transplant (1997) 1.02
[In vitro studies of the occurrence of neuraminidase in Bacteroides species]. Pathol Microbiol (Basel) (1970) 1.01
[Lipase and lecithinase activities of aerobic and anaerobic Corynebacterium and Propionibacterium species]. Zentralbl Bakteriol Orig (1967) 1.01
Familial intradural arachnoid cysts. Report of two cases. J Neurosurg (1979) 1.00
Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. Biochem Biophys Res Commun (1991) 1.00
Nitrocellulose-enzyme-linked immunosorbent assay (NC-ELISA) - a sensitive technique for the rapid visual detection of both viral antigens and antibodies. J Virol Methods (1984) 1.00
Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant (2007) 1.00
Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol (1982) 1.00
Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor. Diabetologia (2010) 1.00
Refractory period, sensory conduction velocity and visual evoked potentials before and after haemodialysis. J Neurol Neurosurg Psychiatry (1981) 0.99
[Propionate negative saccharolytic bacteroides strains (B. oralis)-occurrence, identification, antimicrobial susceptibility and serological behaviour (author's transl)]. Zentralbl Bakteriol Orig A (1977) 0.99
[Immunelectrophoretic studies of the action of Bacteroides, Fusobacterium, Leptotrichia, and Sphaerophorus species on human plasma proteins]. Zentralbl Bakteriol Orig (1971) 0.99
Studies on the regulation of enolases and compartmentation of cytosolic enzymes in Saccharomyces cerevisiae. Biochim Biophys Acta (1987) 0.99
In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis (2000) 0.98
Light chain isotypes selectively associate with heavy chain idiotypes in T-dependent and T-independent dextran-specific precursors. Nature (1981) 0.98